127
Views
0
CrossRef citations to date
0
Altmetric
Review

Future therapeutic treatment of COPD: Struggle between oxidants and cytokines

, &
Pages 205-228 | Published online: 20 Oct 2022

References

  • AbdelhadyHFloresRTanH2005Infliximab treatment for chronic obstructive pulmonary disease (COPD) – a pilot studyProc Am Thorac Soc2A133
  • AdamsJPalombellaVJSausvilleEAProteasome inhibitors1999a novel class of potent and effective antitumor agentsCancer Res5926152210363983
  • AghdassiERoyallDAllardJP1999Oxidative stress in smokers supplemented with vitamin CInt J Vitam Nutr Res69455110052021
  • AgustiAGNogueraASauledaJ2003Systemic effects of chronic obstructive pulmonary diseaseEur Respir J213476012608452
  • AntonicelliFParmentierMDrostEM2002Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cellsFree Radic Biol Med3249250211958950
  • AutenRLRichardsonRMWhiteJR2001Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn ratsJ Pharmacol Exp Ther29990511561067
  • BaldwinASJr1996The NF-kappa B and I kappa B proteins: new discoveries and insightsAnnu Rev Immunol14649838717528
  • BalsRHiemstraPS2006Antimicrobial peptides in COPD – basic biology and therapeutic applicationsCurr Drug Targets77435016787176
  • BarberRBaillieGSBergmannR2004Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokersAm J Physiol Lung Cell Mol Physiol287L3324315047569
  • BarnesPJShapiroSDPauwelsRA2003Chronic obstructive pulmonary disease: molecular and cellular mechanismsEur Respir J226728814582923
  • BarnesPJStockleyRA2005COPD: current therapeutic interventions and future approachesEur Respir J25108410615929966
  • BarnesPJ2006Corticosteroid effects on cell signallingEur Respir J274132616452600
  • Basu-ModakSLuscherPTyrrellRM1996Lipid metabolite involvement in the activation of the human heme oxygenase-1 geneFree Radic Biol Med20887978743975
  • BaxterACooperAKinchinE2006Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonistsBioorg Med Chem Lett16960316297626
  • BerryMAHargadonBShelleyM2006Evidence of a role of tumor necrosis factor alpha in refractory asthmaN Engl J Med35469770816481637
  • BootsAWHaenenGRBastA2003Oxidant metabolism in chronic obstructive pulmonary diseaseEur Respir J Suppl4614s27s14621103
  • BrackeKRD’HulstAIMaesT2006Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient miceJ Immunol1774350916982869
  • BriataPForcalesSVPonassiM2005p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcriptsMol Cell2089190316364914
  • BridgemanMMMarsdenMSelbyC1994Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissueThorax4967058066561
  • BridgesABScottNAParryGJ1993Age, sex, cigarette smoking and indices of free radical activity in healthy humansEur J Med220588261071
  • BrightlingCEMcKennaSHargadonB2005Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax60193815741434
  • BrittonJRPavordIDRichardsKA1995Dietary antioxidant vitamin intake and lung function in the general populationAm J Respir Crit Care Med151138377735589
  • BrodmerkelCMHuberRCovingtonM2005Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344J Immunol1755370816210643
  • BruceCThomasPS2005The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivityToxicol Appl Pharmacol2051263215893540
  • ButoraGMorrielloGJKothandaramanS20064-Amino-2-alkylbutyramides as small molecule CCR2 antagonists with favorable pharmacokinetic propertiesBioorg Med Chem Lett1647152216870431
  • ButterworthMUpshallDGHobbsM1993Elevation of cysteine and replenishment of glutathione in rat lung slices by cysteine isopropylester and other cysteine precursorsBiochem Pharmacol451769748494535
  • CantorJOCerretaJMArmandG1997Further investigation of the use of intratracheally administered hyaluronic acid to ameliorate elastase-induced emphysemaExp Lung Res23229449184790
  • CantorJOShteyngartBCerretaJM2000The effect of hyaluronan on elastic fiber injury in vitro and elastase-induced airspace enlargement in vivoProc Soc Exp Biol Med225657110998200
  • CantorJOCerretaJMOchoaM2005Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysemaExp Lung Res314173016025922
  • CastroACDangLCSoucyF2003Novel IKK inhibitors: betacarbolinesBioorg Med Chem Lett1324192212824047
  • CeledonJCLangeCRabyBA2004The transforming growth factorbeta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)Hum Mol Genet1316495615175276
  • ChabrierPEAuguetMSpinnewynB1999BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategyProc Natl Acad Sci U S A9610824910485910
  • ChanezPVignolaAMO’ShaugnessyT1997Corticosteroid reversibility in COPD is related to features of asthmaAm J Respir Crit Care Med1551529349154853
  • ChengJDiaz EncarnacionMMWarnerGM2005TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent processAm J Physiol Cell Physiol289C9597015930146
  • ChoiAMElbonCLBruceSA1994Messenger RNA levels of lung extracellular matrix proteins during ozone exposureLung17215308295431
  • ChughtaiBO’RiordanTG2004Potential role of inhibitors of neutrophil elastase in treating diseases of the airwayJ Aerosol Med172899815684729
  • ChungKF2006Cytokines as targets in chronic obstructive pulmonary diseaseCurr Drug Targets76758116787167
  • ChurgAWangRDXieC2003alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouseAm J Respir Crit Care Med16819920712689849
  • ChurgATaiHCoulthardT2006Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wallAm J Respir Crit Care Med17413273417008639
  • CorradiMRubinsteinIAndreoliR2003Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1671380612522029
  • CosioBGTsaprouniLItoK2004Theophylline restores histone deacetylase activity and steroid responses in COPD macrophagesJ Exp Med2006899515337792
  • CotgreaveIA1997N-acetylcysteine: pharmacological considerations and experimental and clinical applicationsAdv Pharmacol38205278895810
  • CrossCEO’NeillCAReznickAZ1993Cigarette smoke oxidation of human plasma constituentsAnn N Y Acad Sci6867289discussion 89–90.8512263
  • CrossCEvan der VlietAO’NeillCA1994Oxidants, antioxidants, and respiratory tract lining fluidsEnviron Health Perspect102Suppl 10185917705296
  • CulpittSVRogersDFShahP2003Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med167243112406856
  • CulpittSVRogersDFTravesSL2005Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthmaRespir Med997031015878486
  • De BenedettoFAcetoADraganiB2005Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPDPulm Pharmacol Ther1841715607126
  • De BoerWIvan SchadewijkASontJK1998Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med158195179847291
  • De BoerWI2002Cytokines and therapy in COPD: a promising combination?Chest121209S218S12010854
  • de BoerWI2005Perspectives for cytokine antagonist therapy in COPDDrug Discov Today109310615718158
  • De BoerWIHauCMvan SchadewijkA2006Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary diseaseAm J Clin Pathol1251849216393673
  • De BoerWIAlagappanVKSharmaHS2007Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapyCell Biochem Biophys471314817406066
  • DeanJLSullyGClarkAR2004The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisationCell Signal1611132115240006
  • DecramerMDekhuijzenPNTroostersT2001The bronchitis randomized on NAC cost-utility study (BRONCUS): hypothesis and design BRONCUS-trial CommitteeEur Respir J173293611405507
  • DecramerMRutten-van MolkenMDekhuijzenPN2005Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet36515526015866309
  • DekhuijzenPN2004Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary diseaseEur Respir J236293615083766
  • DelhaseMLiNKarinM2000Kinase regulation in inflammatory responseNature406367810935625
  • DemedtsIKMorel-MonteroALebecqueS2006Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax6119620116308335
  • DentenerMAVernooyJHHendriksS2005Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammationThorax601141915681498
  • DentenerMALouisRClootsRH2006Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha releaseThorax614788416517575
  • DevalarajaRMNanneyLBDuJ2000Delayed wound healing in CXCR2 knockout miceJ Invest Dermatol1152344410951241
  • Di StefanoACapelliALusuardiM2001Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary diseaseClin Exp Allergy3189390211422154
  • DillonTJWalshRLScicchitanoR1992Plasma elastin-derived peptide levels in normal adults, children, and emphysematous subjects. Physiologic and computed tomographic scan correlatesAm Rev Respir Dis146114381443863
  • DueholmMNielsenCThorshaugeH1992N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multicentre studyRespir Med8689921615189
  • DwyerMPYuYChaoJ2006Discovery of 2-Hydroxy-N, N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor AntagonistJ Med Chem497603617181143
  • EdwardsPDAndisikDWBryantCA1997Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastaseJ Med Chem401876859191965
  • Ekberg-JanssonALarsonMMacNeeW1999N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitisEur Respir J138293410362048
  • ErinEMLeakerBRNicholsonGC2006The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthmaAm J Respir Crit Care Med1747536216840747
  • FerraraNGerberHPLeCouterJ2003The biology of VEGF and its receptorsNat Med96697612778165
  • FerryGLonchamptMPennelL1997Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injuryFEBS Lett402111159037177
  • FitzgeraldMFSpicerDMaJY2006Efficacy of the p38 MAP Kinase Inhibitor, SD-282, in an Inflammatory Model of COPD in A/J MiceProc Am Thorac Soc3A850
  • GambleEGrootendorstDCBrightlingCE2003Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1689768212816740
  • GanWQManSFSinDD2005Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysisBMC Pulm Med5315707484
  • GartlehnerGHansenRACarsonSS2006Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesAnn Fam Med42536216735528
  • GerritsCMHeringsRMLeufkensHG2003N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary diseaseEur Respir J21795812765423
  • GhoshSMayMJKoppEB1998NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responsesAnnu Rev Immunol16225609597130
  • GilksCBPriceKWrightJL1998Antioxidant gene expression in rat lung after exposure to cigarette smokeAm J Pathol152269789422544
  • GillissenAJaworskaMOrthM1997Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitroRespir Med91159689135855
  • GosmanMMBoezenHMvan DiemenCC2006A disintegrin and metalloproteinase 33 and chronic obstructive pulmonary disease pathophysiologyThorax62242717090574
  • GosmanMMWillemseBWJansenDF2006Increased number of B-cells in bronchial biopsies in COPDEur Respir J2760416387936
  • GrashoffWFSontJKSterkPJ1997Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophagesAm J Pathol1511785909403729
  • GrievinkLSmitHAOckeMC1998Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN studyThorax53166719659349
  • GrootendorstDCGauwSASterkPJ2005Treatment with PDE4 inhibitor roflumilast reduces sputum neutrophil and eosinophil numbers in patients with COPDProc Am Thoracic Soc2A543
  • GuestTMVlastosGAlameddineFM2006Mechanoregulation of monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cellsAntioxid Redox Signal814617116987003
  • GuidotDMBrownLA2000Mitochondrial glutathione replacement restores surfactant synthesis and secretion in alveolar epithelial cells of ethanol-fed ratsAlcohol Clin Exp Res241070610924012
  • HabibMPTankLJLaneLC1999Effect of vitamin E on exhaled ethane in cigarette smokersChest1156849010084476
  • HaddadEBBirrellMMcCluskieK2001Role of p38 MAP kinase in LPSinduced airway inflammation in the ratBr J Pharmacol13217152411309243
  • HaringmanJJGerlagDMSmeetsTJ2006A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisArthritis Rheum5423879216869001
  • HarjuTKaarteenaho-WiikRSoiniY2002Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers’ lungAm J Respir Crit Care Med166754912204877
  • HarrisonDJCantlayAMRaeF1997Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancerHum Exp Toxicol16356609257159
  • HautamakiRDKobayashiDKSeniorRM1997Requirement for macrophage elastase for cigarette smoke-induced emphysema in miceScience277200249302297
  • HayasakiTKaikitaKOkumaT2006CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in miceCirc J703425116501303
  • HittiEIakovlevaTBrookM2006Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich elementMol Cell Biol26239940716508014
  • HoKKAuldDSBohnstedtAC2006Imidazolylpyrimidine based CXCR2 chemokine receptor antagonistsBioorg Med Chem Lett162724816540318
  • HoggJC2004Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet3647092115325838
  • Holmes-McNaryMBaldwinASJr2000Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinaseCancer Res6034778310910059
  • HoogendoornMFeenstraTLRutten-van MolkenMP2006[Projections of future resource use and the costs of asthma and COPD in the Netherlands]Ned Tijdschr Geneeskd15012435016796176
  • HowarthPHBabuKSArshadHS2005Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthmaThorax6010121816166100
  • HuangSMWuCHYenGC2006Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEsMol Nutr Food Res5011293917103373
  • HynninenKMBreitveMHWiborgAB2005Psychological characteristics of patients with chronic obstructive pulmonary disease: a reviewJ Psychosom Res594294316310027
  • ItoKLimSCaramoriG2001Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophagesFaseb J1511101211292684
  • ItoKItoMElliottWM2005Decreased histone deacetylase activity in chronic obstructive pulmonary diseaseN Engl J Med35219677615888697
  • JazrawiECosioBGBarnesPJ2003Inhibition of IKK2 and JNK differentially regulates GM-CSF and IL-8 release in epithelial cells and alveolar macrophagesAm J Respir Crit Care Med167A798
  • JohnsonGLLapadatR2002Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinasesScience29819111212471242
  • JonesPW2006Health status: what does it mean for payers and patients?Proc Am Thorac Soc3222616636089
  • JoosLHeJQShepherdsonMB2002The role of matrix metalloproteinase polymorphisms in the rate of decline in lung functionHum Mol Genet115697611875051
  • KarimiKSarirHMortazE2006Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophagesRespir Res76616620395
  • KasaharaYTuderRMTaraseviciene-StewartL2000Inhibition of VEGF receptors causes lung cell apoptosis and emphysemaJ Clin Invest10613111911104784
  • KasielskiMNowakD2001Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary diseaseRespir Med954485611421501
  • KassimSYFuXLilesWC2005NADPH oxidase restrains the matrix metalloproteinase activity of macrophagesJ Biol Chem28030201515983040
  • KeatingsVMCaveSJHenryMJ2000A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPDChest118971511035665
  • KirkhamPASpoonerGRahmanI2004Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation productsBiochem Biophys Res Commun31832715110749
  • KoechlinCCouillardACristolJP2004Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?Eur Respir J235384415083751
  • KoetheSMKuhnmuenchJRBeckerCG2000Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibodyAm J Pathol15717354311073832
  • KondoTTagamiSYoshiokaA1994Current smoking of elderly men reduces antioxidants in alveolar macrophagesAm J Respir Crit Care Med149178828111579
  • KranenburgARDe BoerWIVan KriekenJH2002Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol275172512397010
  • KranenburgARde BoerWIAlagappanVK2005Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary diseaseThorax601061315681497
  • KranenburgARWillems-WidyastutiAMooriWJ2006Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary diseaseAm J Clin Pathol1267253517111536
  • KucukaycanMVan KrugtenMPenningsHJ2002Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary diseaseRespir Res32912537602
  • KumagaiTMatsukawaNKanekoY2004A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophagesJ Biol Chem279483899615355999
  • KumarSBoehmJLeeJC2003p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNat Rev Drug Discov27172612951578
  • LangMRFiauxGWGilloolyM1994Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungsThorax49319268202900
  • LangenRCKornSHWoutersEF2003ROS in the local and systemic pathogenesis of COPDFree Radic Biol Med352263512885585
  • LeeJCKassisSKumarS1999p38 mitogen-activated protein kinase inhibitors – mechanisms and therapeutic potentialsPharmacol Ther823899710454214
  • LeffAR2006Tissue remodeling and repair mechanisms in chronic obstructive pulmonary diseaseProc Am Thorac Soc37346
  • LiaoLNingQLiY2006CXCR2 blockade reduces radical formation in hyperoxia-exposed newborn rat lungPediatr Res6029930316923948
  • LindbergABjerg-BacklundARonmarkE2006Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden StudiesRespir Med1002647215975774
  • LindholtJSJorgensenBShiGP2003Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysmsEur J Vasc Endovasc Surg255465112787697
  • LokeWMProudfootJMMcKinleyAJ2006Augmentation of monocyte intracellular ascorbate in vitro protects cells from oxidative damage and inflammatory responsesBiochem Biophys Res Commun34510394316712788
  • LykkesfeldtJChristenSWallockLM2000Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakesAm J Clin Nutr71530610648268
  • MaenoTHoughtonAMQuinteroPA2007CD8+ T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in miceJ Immunol1788090617548647
  • Martin-MosqueroCPeces-BarbaGRubioML2006Increased collagen deposition correlated with lung destruction in human emphysemaHistol Histopathol21823816691534
  • MarwickJAKirkhamPAStevensonCS2004Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungsAm J Respir Cell Mol Biol316334215333327
  • MarwickJAStevensonCSGiddingsJ2006Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibitionAm J Physiol Lung Cell Mol Physiol290L89790816361360
  • MatsuokaHAraiTMoriM2002A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosisAm J Physiol Lung Cell Mol Physiol283L1031212060566
  • McCuskerKHoidalJ1990Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamstersAm Rev Respir Dis141678822310098
  • MejaKKSeldonPMNasuharaY2000p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanismBr J Pharmacol13111435311082122
  • MenezesAMPerez-PadillaRJardimJR2005Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet36618758116310554
  • MezzettiALapennaDPierdomenicoSD1995Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and nonsmokersAtherosclerosis1129197772072
  • MilatovicSNanneyLBYuY2003Impaired healing of nitrogen mustard wounds in CXCR2 null miceWound Repair Regen112131912753603
  • MonteleoneGKumberovaACroftNM2001Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel diseaseJ Clin Invest108601911518734
  • MoodieFMMarwickJAAndersonCS2004Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cellsFaseb J181897915456740
  • MorettiMBottrighiPDallariR2004The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE StudyDrugs Exp Clin Res301435215553660
  • MorquetteBShiQLavigneP2006Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradationArthritis Rheum542718116385544
  • MorrisonDRahmanILannanS1999Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokersAm J Respir Crit Care Med159473799927360
  • MullerKHardwickSJMarchantCE1996Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophagesFEBS Lett38816588690078
  • NasuharaYAdcockIMCatleyM1999Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells Evidence for additional regulatory steps in kappaB-dependent transcriptionJ Biol Chem274199657210391945
  • NeurohrCLenzAGDingI2003Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokersEur Respir J2282712882455
  • NicholsonGCTennantRCCarpenterDC2007A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonistPulm Pharmacol Ther2052916406722
  • NishiTMaierCMHayashiT2005Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemiaJ Cereb Blood Flow Metab2513122415829914
  • NishikawaMKakemizuNItoT1999Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivoAm J Respir Cell Mol Biol20189989922209
  • NogueraABusquetsXSauledaJ1998Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med158166489817722
  • OgryzkoVVSchiltzRLRussanovaV1996The transcriptional coactivators p300 and CBP are histone acetyltransferasesCell8795398945521
  • OkadaYWatanabeSNakanishiI1988Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinasesFEBS Lett229157603162216
  • PapiARomagnoliMBaraldoS2000Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1621773711069811
  • ParasrampuriaDAde BoerPDesai-KriegerD2003Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human studyJ Clin Pharmacol434061312723461
  • ParolaMPinzaniMCasiniA1993Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cellsBiochem Biophys Res Commun1941044508352762
  • PasternakAMarinoDVicarioPP2006Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonistsJ Med Chem494801416884289
  • PauwelsRARabeKF2004Burden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet3646132015313363
  • PembertonPAKobayashiDWilkBJ2006Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouseCopd3101817175673
  • PetruzzelliSHietanenEBartschH1990Pulmonary lipid peroxidation in cigarette smokers and lung cancer patientsChest9893052209151
  • PizzichiniEPizzichiniMMGibsonP1998Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitisAm J Respir Crit Care Med1581511179817701
  • PoolePJBlackPN2006Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev3CD00128716855965
  • PostmaDSTimensW2006Remodeling in asthma and chronic obstructive pulmonary diseaseProc Am Thorac Soc3434916799088
  • RabeKFBatemanEDO’DonnellD2005Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialLancet3665637116099292
  • RahmanIAdcockIM2006Oxidative stress and redox regulation of lung inflammation in COPDEur Respir J282194216816350
  • RahmanIMacNeeW1996aOxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary diseaseThorax51348508733482
  • RahmanIMacNeeW1996bRole of oxidants/antioxidants in smoking-induced lung diseasesFree Radic Biol Med21669818891669
  • RahmanIMacNeeW1998Role of transcription factors in inflammatory lung diseasesThorax53601129797762
  • RahmanIMacNeeW1999Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway diseaseAm J Physiol277L10678810600876
  • RahmanIMacNeeW2000aOxidative stress and regulation of glutathione in lung inflammationEur Respir J165345411028671
  • RahmanIMacNeeW2000bRegulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approachesFree Radic Biol Med2814052010924859
  • RahmanIMorrisonDDonaldsonK1996Systemic oxidative stress in asthma, COPD, and smokersAm J Respir Crit Care Med1541055608887607
  • RahmanISkwarskaEMacNeeW1997Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary diseaseThorax5256589227727
  • RahmanIGilmourPSJimenezLA2002Oxidative stress and TNFalpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammationMol Cell Biochem234523948
  • RahmanIvan SchadewijkAACrowtherAJ20024-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med166490512186826
  • RahmanIMarwickJKirkhamP2004Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expressionBiochem Pharmacol6812556715313424
  • RajagopalanSMengXPRamasamyS1996Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stabilityJ Clin Invest98257298958220
  • RasmussenJBGlennowC1988Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitisEur Respir J135153294038
  • RautalahtiMVirtamoJHaukkaJ1997The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptomsAm J Respir Crit Care Med1561447529372659
  • RayPDevauxYStolzDB2003Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxiaProc Natl Acad Sci U S A100609810312732722
  • RennardSIFogartyCKelsenSfor the COPD Investigators2007The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1759263417290043
  • RennardSISchachterNStrekM2006Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4Chest129566616424413
  • RennekampffHOHansbroughJFWoodsVJr1997Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healingArch Dermatol Res289204129143736
  • RennekampffHOHansbroughJFKiessigV2000Bioactive interleukin-8 is expressed in wounds and enhances wound healingJ Surg Res93415410945942
  • RepineJEBastALankhorstI1997Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study GroupAm J Respir Crit Care Med156341579279209
  • RolinSMasereelBDogneJM2006Prostanoids as pharmacological targets in COPD and asthmaEur J Pharmacol5338910016458293
  • RothSYDenuJMAllisCD2001Histone acetyltransferasesAnnu Rev Biochem708112011395403
  • RussellRECulpittSVDeMatosC2002Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol26602911970913
  • RusznakCMillsPRDevaliaJL2000Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol23530611017919
  • SadowskaAMManuelYKBDe BackerWA2007Antioxidant and antiinflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a reviewPulm Pharmacol Ther2092216458553
  • SaettaMBaraldoSCorbinoL1999CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1607111710430750
  • SaikaSIkedaKYamanakaO2005Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkaliAm J Pathol16614051815855641
  • SandfordAJChaganiTWeirTD2001Susceptibility genes for rapid decline of lung function in the lung health studyAm J Respir Crit Care Med1634697311179124
  • SargeantLAJaeckelAWarehamNJ2000Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk. European Prospective Investigation into Cancer and NutritionEur Respir J1639740311028650
  • SchaurRJDussingGKinkE1994The lipid peroxidation product 4-hydroxynonenal is formed by – and is able to attract – rat neutrophils in vivoFree Radic Res20365738081452
  • ScottDAStapletonJAWilsonRF2000Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smokingBlood Cells Mol Dis26255810950946
  • ShaharEBolandLLFolsomAR1999Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease. The Atherosclerosis Risk in Communities Study InvestigatorsAm J Respir Crit Care Med1591780510351918
  • ShapiroSDGoldsteinNMHoughtonAM2003Neutrophil elastase contributes to cigarette smoke-induced emphysema in miceAm J Pathol16323293514633606
  • ShenYRattanVSultanaC1996Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytesAm J Physiol270H1624338928867
  • SinDDAnthonisenNRSorianoJB2006Mortality in COPD: role of comorbiditiesEur Respir J2812455717138679
  • SmithKRUyeminamiDLKodavantiUP2002Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidantFree Radic Biol Med3311061412374622
  • SniderGL1989Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesisAnnu Rev Med40411292658758
  • SpringerJScholzFRPeiserC2004SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smokeBiol Chem3856495315318814
  • SpycherSETabataba-VakiliSO’DonnellVB1997Aldose reductase induction: a novel response to oxidative stress of smooth muscle cellsFaseb J1118189039961
  • SteinbergFMChaitA1998Antioxidant vitamin supplementation and lipid peroxidation in smokersAm J Clin Nutr68319279701189
  • SteinerovaARacekJStozickyF2001Antibodies against oxidized LDL – theory and clinical usePhysiol Res501314111522041
  • SteyCSteurerJBachmannS2000The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic reviewEur Respir J162536210968500
  • StonePJGottliebDJO’ConnorGT1995Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary diseaseAm J Respir Crit Care Med15195297697272
  • SullivanAKSimonianPLFaltaMT2005Oligoclonal CD4+ T cells in the lungs of patients with severe emphysemaAm J Respir Crit Care Med172590615937291
  • TakizawaHTanakaMTakamiK2001Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)Am J Respir Crit Care Med16314768311371421
  • Taraseviciene-StewartLScerbaviciusRChoeKH2005An animal model of autoimmune emphysemaAm J Respir Crit Care Med1717344215563631
  • TjalkensRBCookLWPetersenDR1999Formation and export of the glutathione conjugate of 4-hydroxy-2, 3-E-nonenal (4-HNE) in hepatoma cellsArch Biochem Biophys361113199882435
  • TsaiSHLin-ShiauSYLinJK1999Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrolBr J Pharmacol1266738010188978
  • TuderRMZhenLChoCY2003Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockadeAm J Respir Cell Mol Biol29889712600822
  • TuderRMYoshidaTArapW2006State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspectiveProc Am Thorac Soc35031016921129
  • TugTKaratasFTerziSM2004Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary diseaseClin Invest Med27123815305803
  • UnderwoodDCOsbornRRBochnowiczS2000SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lungAm J Physiol Lung Cell Mol Physiol279L89590211053025
  • UnderwoodDCOsbornRRKotzerCJ2000SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistenceJ Pharmacol Exp Ther293281810734180
  • UneriCSariMBaglamT2006Effects of vitamin E on cigarette smoke induced oxidative damage in larynx and lungLaryngoscope1169710016481818
  • van AntwerpenLTheronAJMyerMS1993Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E, and tissue injuryAnn N Y Acad Sci68653658512261
  • van der StrateBWPostmaDSBrandsmaCA2006Cigarette smoke-induced emphysema: A role for the B cell?Am J Respir Crit Care Med173751816399994
  • van der VaartHKoeterGHPostmaDS2005First study of infliximab treatment in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med172465915937294
  • Van SchootenFJBesaratiniaADe FloraS2002Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokersCancer Epidemiol Biomarkers Prev111677511867504
  • VincentSHPainterSKLuffer-AtlasD1997Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeysDrug Metab Dispos2593299280401
  • VoelkelNFCollCD2003Pulmonary vascular involvement in chronic obstructive pulmonary diseaseEur Respir J Suppl4628s32s14621104
  • WangRDTaiHXieC2003Cigarette smoke produces airway wall remodeling in rat tracheal explantsAm J Respir Crit Care Med1681232612958058
  • WeathingtonNMvan HouwelingenAHNoeragerBD2006A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammationNat Med123172316474398
  • WrightJLFarmerSGChurgA2002Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigsAm J Respir Crit Care Med1669546012359653
  • WrightJLChurgA2006Advances in the pathology of COPDHistopathology491916842241
  • YangSRChidaASBauterMR2006Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophagesAm J Physiol Lung Cell Mol Physiol291L465716473865
  • YoshidaMKorfhagenTRWhitsettJA2001Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathwaysJ Immunol16675141911390505
  • YoungRPHopkinsRBlackPN2006Functional variants of antioxidant genes in smokers with COPD and in those with normal lung functionThorax61394916467073
  • ZandvoortAPostmaDSJonkerMR2006Altered expression of the Smad signalling pathway: implications for COPD pathogenesisEur Respir J285334116707515